David Wehner active positions
| Companies | Position | Start | End |
|---|---|---|---|
Venneos GmbH
 Venneos GmbH BiotechnologyHealth Technology Venneos GmbH develops an imaging system for the analysis of biological cells. Its products include CAN-Q station, CAN-Q chip, CAn-Q analyzer and demonstration. The firm technology CAN Spectroscopy, brings cell-based assays to the next level: Label-free and non-invasive readout, analysis on a single cell level and a broad spectrum of detectable and distinguishable cellular effects. The company was founded by David Wehner and Jon H. Lehmann in 2014 and is headquartered in Stuttgart, Germany. | Chief Executive Officer | 2013-12-31 | - |
| Founder | 2013-12-31 | - | |
SHS Gesellschaft für Beteiligungsmanagement mbH
 SHS Gesellschaft für Beteiligungsmanagement mbH Investment ManagersFinance SHS Gesellschaft für Beteiligungsmanagement mbH (SHS) is an independent private equity and venture capital firm founded by Bernhard Schirmers and Reinhilde Spatscheck in 1993, and was headquartered in Tübingen, Baden-Württemberg in the southwest of Germany. | Private Equity Investor | 2019-08-31 | - |
Career history of David Wehner
Statistics
International
| Germany | 3 |
Operational
| Chief Executive Officer | 1 |
| Founder | 1 |
| Private Equity Investor | 1 |
Sectoral
| Finance | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
SHS Gesellschaft für Beteiligungsmanagement mbH
SHS Gesellschaft für Beteiligungsmanagement mbH Investment ManagersFinance SHS Gesellschaft für Beteiligungsmanagement mbH (SHS) is an independent private equity and venture capital firm founded by Bernhard Schirmers and Reinhilde Spatscheck in 1993, and was headquartered in Tübingen, Baden-Württemberg in the southwest of Germany. | Finance |
Venneos GmbH
Venneos GmbH BiotechnologyHealth Technology Venneos GmbH develops an imaging system for the analysis of biological cells. Its products include CAN-Q station, CAN-Q chip, CAn-Q analyzer and demonstration. The firm technology CAN Spectroscopy, brings cell-based assays to the next level: Label-free and non-invasive readout, analysis on a single cell level and a broad spectrum of detectable and distinguishable cellular effects. The company was founded by David Wehner and Jon H. Lehmann in 2014 and is headquartered in Stuttgart, Germany. | Health Technology |
- Stock Market
- Insiders
- David Wehner
- Experience
